MEAKSS, a synthetic polypeptide, is emerging as a promising therapeutic for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates significant restorative effects by regulating key cellular pathways involved in neuronal survival. Studies suggest that MEAKSS can enhance synaptogenesis, {reduceneurotoxicity, and optimiz